Tale Of Science Rivalry Marks Chemist's Debut As Novelist

This is not science fiction, but “science in fiction,” says Carl Djerassi, the celebrated Stanford chemist whose first novel, Cantor’s Dilemma, is being published this month by Doubleday. The novel portrays what Djerassi calls “the soul and baggage of contemporary science,” including its brutal competition, baroque professional etiquette, and complicated relations between professors and their students. Nearly all its science is real; also, real-life scientists and

| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

This is not science fiction, but “science in fiction,” says Carl Djerassi, the celebrated Stanford chemist whose first novel, Cantor’s Dilemma, is being published this month by Doubleday. The novel portrays what Djerassi calls “the soul and baggage of contemporary science,” including its brutal competition, baroque professional etiquette, and complicated relations between professors and their students. Nearly all its science is real; also, real-life scientists and their work appear in context. Cantor’s Dilemma focuses on the issue of scientific fraud, which, Djerassi demonstrates, is often not a case of black and white, but a gray and misted region full of pitfalls for the easy moralist.

Djerassi’s protagonist, I. Cantor, is a highly respected cell biologist at a university in the Midwest. In these excerpts, Djerassi describes how Cantor pushes his brilliant postdoc Jerry Stafford for experimental verification of Cantor’s radical newthe- ory of tumori genesis—a theory that, the professor knows, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Carl Djerassi

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours